| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Charles River Laboratories International, Inc. (CRL) has 18 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. CRL is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 210.7K | $34.31M | - | |
| COO | 65.9K | $10.74M | - | |
| VP | 29.2K | $4.75M | - | |
| VP | 27.4K | $4.46M | - | |
| CFO | 17.3K | $2.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2020 | Smith David Ross63 | Corporate Executive VP &CFO | Sale+OE | 3,304 | $216.54 | $715,443.83 | -7.2% | |
| Aug 7, 2020 | Foster James C77 | Chairman, President And CEO | Sell | 24,000 | $217.49 | $5,219,771.27 | -5.2% | |
| May 22, 2020 | Massaro George66 | Director | Sell | 941 | $173.40 | $163,168.18 | -2.5% | |
| May 20, 2020 | Bertolini Robert J | Director | Sale+OE | 3,530 | $174.58 | $616,262.81 | -10.8% | |
| May 18, 2020 | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sale+OE | 15,768 | $168.40 | $2,655,297.84 | -31.4% | |
| May 18, 2020 | Foster James C77 | Chairman, President And CEO | Sell | 17,435 | $175.00 | $3,051,125.00 | -7.0% | |
| May 12, 2020 | Girshick Birgit65 | Corporate Executive VP | Sell | 780 | $165.74 | $129,277.20 | -3.4% | |
| May 11, 2020 | Foster James C77 | Chairman, President And CEO | Sell | 17,446 | $162.53 | $2,835,432.64 | -1.3% | |
| May 7, 2020 | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 1,884 | $150.00 | $282,600.00 | -9.2% | |
| Mar 5, 2020 | Barbo William D66 | Corporate Executive VP &CCO | Sale+OE | 13,966 | $164.35 | $2,295,299.65 | -27.1% |